Colonoscopy Clinical Trial
Official title:
Propofol Patient-controlled Sedation Versus Target-controlled Infusion in Outpatient Colonoscopy
Verified date | December 2020 |
Source | Universiti Kebangsaan Malaysia Medical Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This was a prospective, randomized, single-blind controlled clinical trial comparing three sedative regimens for outpatient colonoscopy.
Status | Completed |
Enrollment | 105 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - ASA I or II patients - aged between 18 to 80 years - scheduled for outpatient colonoscopy Exclusion Criteria: - history of or with psychiatric disease - on psychoactive drugs - mentally or physically unable to use the hand-held device for PCS - previous complications from anaesthesia or sedation - potentially difficult airway maintenance - obstructive sleep apnoea - pregnant - with contraindications to the study drugs |
Country | Name | City | State |
---|---|---|---|
Malaysia | Pusat Perubatan Universiti Kebangsaan Malaysia | Cheras | Kuala Lumpur |
Lead Sponsor | Collaborator |
---|---|
Universiti Kebangsaan Malaysia Medical Centre |
Malaysia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Time taken to onset of sedation | Time taken for patient to reach a sedation score of MOAAS 3 or 4 | From start of sedation until MOAAS 3 or 4 attained, assessed up to one hour from the point sedation was commenced | |
Primary | Recovery time to Modified Observer's Assessment of Alertness and Sedation Scale (MOAAS) | Recovery of patient from sedation when MOAAS 5 is achieved | From time of arrival at the recovery area after completion of colonoscopy, until point of discharge from recovery area, assessed up to 2 hours post arrival at recovery | |
Primary | Recovery time to ambulation | Recovery of patient from sedation when patient starts ambulating | From time of arrival at the recovery area after completion of colonoscopy, until the point patient starts to ambulate, assessed up to 2 hours post arrival at recovery | |
Primary | Recovery time to discharge | Recovery of patient from sedation when patient is deemed fit for discharge home | From time of arrival at the recovery area after completion of colonoscopy, until the point patient is deemed fit for discharge home, assessed up to 2 hours post arrival at recovery | |
Primary | Endoscopist satisfaction score | After completion of colonoscopy, the endoscopist graded on a scale of 1 to 10, ease of the colonoscopy/procedure (1 = very difficult, 10 = very easy), and level of satisfaction (1 = very dissatisfied, 10 = very satisfied) using a 10 cm visual analog scale (VAS). | After completion of colonoscopy, the endoscopist graded his satisfaction score from the start of colonoscopy, assessed until 2 hours after completion of colonoscopy | |
Primary | Patient satisfaction score | After completion of colonoscopy, the patient graded on a scale of 1 to 10, the level of satisfaction (1 = very dissatisfied, 10 = very satisfied) using a 10 cm visual analog scale (VAS). | Patient satisfaction score from start of sedation until point of discharge from recovery assessed until 3 hours from the start of sedation | |
Primary | Patient willingness to repeat the same sedation technique | Patient responds yes or no. to willingness of having the same sedation during colonoscopy, in the future | From patient arrival to recovery post colonoscopy, area until the point of patient discharge, assessed up to 3 hours after arrival at recovery | |
Secondary | Rescue analgesic drug requirement | Requirement for rescue analgesic or sedative in addition to study drugs/sedatives, during the entire duration of colonoscopy | From start of sedation, and during the entire duration of colonoscopy, assessed up to 2 hours from the start of sedation | |
Secondary | Total drug consumption | Total consumption of all study drugs from the start of sedation, during the entire duration of colonoscopy until completion of colonoscopy | Total consumption of all study drugs from the start of sedation, during the entire duration of colonoscopy until completion of colonoscopy, assessed up to 2 hours from the start of sedation | |
Secondary | Ease of colonoscopy score | endoscopist graded on a scale of 1 to 10, ease of procedure (1 = very difficult, 10 = very easy) | during the entire duration of colonoscopy from the start of colonoscopy, assessed up to 2 hours from the start of colonoscopy | |
Secondary | Recalled events during colonoscopy | The number of recalled events during the entire duration of colonoscopy | Recalled events retrieved from patient, from arrival to recovery area until point of discharge home, assessed up to 2 hours from arrival at recovery | |
Secondary | Recalled discomfort/ pain during colonoscopy | The number of recalled events of discomfor/pain during the entire duration of colonoscopy | Recalled events of discomfort/pain retrived from the patient, from arrival to recovery area until point of discharge home, assessed up to 2 hours from arrival at recovery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04101097 -
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
|
||
Completed |
NCT03247595 -
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy
|
N/A | |
Completed |
NCT04214301 -
An Open-Label Preference Evaluation of BLI800
|
Phase 4 | |
Withdrawn |
NCT05754255 -
Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center
|
N/A | |
Recruiting |
NCT02484105 -
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
|
Phase 4 | |
Active, not recruiting |
NCT02264249 -
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
|
N/A | |
Terminated |
NCT01978509 -
The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies
|
N/A | |
Completed |
NCT01964417 -
The Comparative Study Between Bowel Preparation Method
|
Phase 3 | |
Recruiting |
NCT01685970 -
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
|
Phase 3 | |
Completed |
NCT01518790 -
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
|
N/A | |
Recruiting |
NCT00748293 -
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
|
N/A | |
Completed |
NCT00779649 -
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
|
Phase 4 | |
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT00380497 -
Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
|
Phase 4 | |
Recruiting |
NCT00160823 -
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
|
Phase 3 | |
Completed |
NCT00314418 -
Patient Position and Impact on Colonoscopy Time
|
N/A | |
Completed |
NCT00390598 -
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
|
Phase 2/Phase 3 | |
Completed |
NCT00427089 -
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
|
Phase 3 | |
Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
Completed |
NCT05823350 -
The Effect of Abdominal Massage on Pain and Distention After Colonoscopy
|
N/A |